Co-Diagnostics, Inc.

CODXNASDAQHealthcare● Active

$5.05

$-0.58(-10.30%)

Market Cap$5637042

P/E Ratio—

52W High$46.5

52W Low$1.26

Avg Volume6.6M

Open$5.53

Beta2.75

Overview

Co-Diagnostics, Inc. (CODX) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

CODX · net income · updated Jun 8, 2026

Core profitability metrics

CODX · net income · margin · TTM · CAGR

Net income was −$46.9M for FY2025 (fiscal year ending 2025-12-31), down 24.6% year-over-year. Net profit margin was -7533.6%. Based on available data, Co-Diagnostics, Inc. has been profitable since at least 2020.

FY2025 Net Income−$46.9M▼ -24.6% YoY

Trailing 12M (TTM)−$48.5Mtrailing 4 quarters sum

Net Profit Margin< −999%−$46.9M ÷ $622,489

YoY Change-24.6%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2020

▸ FMP /income-statement · Annual · CODX net income history · CODX profit margin

Annual net income data

CODX · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$46.9M▼ 24.6%-7533.6%$622,489

FY2024Loss−$37.6M▼ 6.5%-961.4%$3.9M

FY2023Loss−$35.3M▼ 148.2%-518.7%$6.8M

FY2022Loss−$14.2M▼ 138.8%-41.6%$34.2M

FY2021$36.7M▼ 13.7%37.5%$97.9M

Net income vs peers (Healthcare)

CODX vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Co-Diagnostics, Inc.YOU

CODX

−$46.9M-24.6%-7533.6%

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Co-Diagnostics, Inc. (CODX) reported net income of −$46.9M for FY2025 (fiscal year ending 2025-12-31), down 24.6% year-over-year. The net profit margin was -7533.6% — meaning the company kept $-75.34 of every dollar of revenue as profit.

Based on available data, Co-Diagnostics, Inc. has been profitable since at least 2020. Net income reached a peak of $42.5M in FY2020. Data available for 12 fiscal years.

Co-Diagnostics, Inc.'s net profit margin was -7533.6% for FY2025, based on the latest annual results.

Investors sometimes search for "Co-Diagnostics, Inc. net worth" — the company's market capitalization is a separate figure from CODX net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

CODX net income · 4 questions

Co-Diagnostics, Inc. is not currently profitable on an annual basis. The company reported a net loss of $46.9M for FY2025.

is CODX profitabledoes CODX make a profitCODX profitabilityCODX profitable company

▸ Source: FMP /income-statement · GAAP · Co-Diagnostics, Inc. · Co-Diagnostics, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026